Category Archive for ‘BioTech’

February 3, 2014

MomentumOptionsTrading.com Weekly Wrap Profit Alert for 2/3/2014

by mome2143 / Posted in Momentum Stocks Weekly, BioTech

3:15pm (EST) We have action to take on a trade in our Weekly Wrap newsletter that returned us 41%. We got into the stock at $4.95 in early December and shares recently traded to a high of $9.74. We have been adjusting our stop up to lock-in profits and withRead more

November 11, 2013

ViroPharma Jumps 25%, Call Options 900%/ New Trades!!!

by mome2143 / Posted in Market Analysis, Momentum Stocks Weekly, BioTech

(Special 1-Year Subscription Offers – Guess the Dow, Win a NEW iPad!) 12:05pm (EST) (Special Note: Please go to our website today to see all of the charts and quotes. Also, if you are a current subscribers, please go to the Members Area to see the charts. They will helpRead more

April 25, 2013

SPECIAL OFFER!/ S&P Testing All-Time Highs/ Amazon (AMZN) After the Bell/ New Trade!

by Rick Rouse / Posted in Earnings, Market Analysis, Economic News, Momentum Stocks Weekly, Covered Calls, Market Commentary, BioTech

12:40pm (EST) The bulls are pushing all-time highs ahead of tomorrow’s GDP (Gross Domestic Product) report and all signs are pointing to a break out of the current trading range to new highs or a pullback and a test back down to the bottom of the trading range. Amazon.com (AMZN,Read more

December 7, 2012

Special Offer Membership and Chance to Win an iPad

by Rick Rouse / Posted in Oil, BioTech, Commodities, Money Management, Economic News, Politics, Company Commentary, Mergers and Acquisitions, Apple, Daily Update, Option Trades, China, Earnings, Covered Calls, IPOs, Market Commentary, Market Analysis, Entertainment Stocks

12:05pm (EST) We love Christmas time as it is our favorite holiday of the year. It is nice to receive cards, letters, and gifts but it is more about caring. Our subscribers mean a lot to us and every year we offer a huge discount on yearly memberships because weRead more

August 7, 2012

Market Above Resistance, Pfizer (PFE) Slips

by Rick Rouse / Posted in Daily Update, BioTech

1:35pm (EST) Over the years, we have covered quite a few explosive biotech stocks that have made incredible returns for our subscribers but sometimes we can overlook the 800-pound gorillas in the room. We have been following shares of Pfizer (PFE, $23.84, down $0.42) for years but we rarely, ifRead more

June 27, 2012

MomentumOptionsTrading.com Profit Alert (ARNA)/ New Trade for 6/27/2012

by Rick Rouse / Posted in Momentum Stocks Weekly, BioTech, Trade Update

2:15pm (EST) We always say plan your trades and trade your plan. Arena Pharmaceuticals (ARNA, $11.87, up $3.02) has opened for trading and we are seeing strong gains on our options. We recommended the July 3 calls (ARNA120723C00003000, $9.00, up $3.00) at $1 back in late April and after locking-inRead more

June 27, 2012

Arena Pharmaceuticals (ARNA) Wins Approval, Shares Halted

by Rick Rouse / Posted in Daily Update, BioTech

1:00pm (EST) The bulls are making another push higher and have cracked the first layer of resistance as we head into the second half of trading. We mentioned this morning inside our Members Area that the current choppy action could continue for a few weeks if the market followed lastRead more

June 21, 2012

Bears Starting to Stir

by Rick Rouse / Posted in Daily Update, Market Analysis, Market Commentary, BioTech

12:15pm (EST) The market got a slight pop at the open despite disappointing jobless claims numbers as the bulls try to clear the last few hurdles before a jailbreak. The bears were waiting for the economic news after the start of trading to confirm if this is a good entryRead more

June 13, 2012

Dimon in the Rough

by Rick Rouse / Posted in Market Commentary, BioTech, Daily Update, Market Analysis, Economic News

1:00pm (EST) The market has traded in a tighter range today, surprisingly, with the action favoring the bears. Futures were pointing towards a lower open before the release of this morning’s Producer Price Index (PPI) and dipped a little further after disappointing the suit-and-ties. For May, PPI fell 1.0%, whichRead more

June 11, 2012

Arena Pharmaceuticals (ARNA) Pops Past $7

by Rick Rouse / Posted in BioTech, Daily Update, Market Analysis, Option Trades

12:30pm (EST) The $125 billion Spain Bank Aid has turned into a temporary bank aid that Wall Street isn’t buying as the market is trading lower heading into the second half of trading. Futures were showing a strong open when we hit the rack last night but were cut inRead more

CFTC Disclosure:

GOVERNMENT REGULATIONS REQUIRE DISCLOSURE OF THE FACT THAT WHILE THESE METHODS MAY HAVE WORKED IN THE PAST, PAST PERFORMANCE IS NOT NECESSARILY INDICATIVE OF FUTURE PERFORMANCE. WHILE THERE IS A POTENTIAL FOR PROFITS THERE IS ALSO A RISK OF LOSS. A LOSS INCURRED IN CONNECTION WITH Momentum Options Trading, LLC CAN BE SIGNIFICANT. YOU SHOULD THEREFORE CAREFULLY CONSIDER WHETHER TRADING IS SUITABLE FOR YOU IN LIGHT OF YOUR FINANCIAL CIRCUMSTANCE. THERE IS SUBSTANTIAL RISK IN TRADING. A LOSS INCURRED IN CONNECTION WITH FUTURES TRADING CAN BE SIGNIFICANT. WE MAKE NO CLAIM REGARDING PAST OR FUTURE PERFORMANCE. WE MERELY TRACK EVERY TRADE AND SHOW THE PERFORMANCE OF ALL TRADES THE SYSTEM OR NEWSLETTER PRODUCES. SIMULATED TRADING IS DIFFERENT THAN TRADING REAL MONEY. HYPOTHETICAL RESULTS ARE NOT REAL RESULTS. PLEASE CONTACT YOUR BROKER ABOUT THE RISK OR TRADING STOCKS, OPTIONS OR FUTURES. ALL COMMUNICATIONS ARE OPINIONS NOT ADVICE.

CFTC RULE 4.41 – HYPOTHETICAL OR SIMULATED PERFORMANCE RESULTS HAVE CERTAIN LIMITATIONS. UNLIKE AN ACTUAL PERFORMANCE RECORD, SIMULATED RESULTS DO NOT REPRESENT ACTUAL TRADING. ALSO, SINCE THE TRADES HAVE NOT BEEN EXECUTED, THE RESULTS MAY HAVE UNDER-OR-OVER COMPENSATED FOR THE IMPACT, IF ANY, OF CERTAIN MARKET FACTORS, SUCH AS LACK OF LIQUIDITY. SIMULATED TRADING PROGRAMS IN GENERAL ARE ALSO SUBJECT TO THE FACT THAT THEY ARE DESIGNED WITH THE BENEFIT OF HINDSIGHT. NO REPRESENTATION IS BEING MADE THAT ANY ACCOUNT WILL OR IS LIKELY TO ACHIEVE PROFIT OR LOSSES SIMILAR TO THOSE SHOWN.